Sickle cell disease in pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 37, Issue 2, 2010, Pages 223-237

  Rogers, Dennie T ^a   Molokie, Robert ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Anemia; Genetic disease; Hemoglobinopathy; Pregnancy; Sickle cell disease

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTIBIOTIC AGENT; BETA GLOBIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERRITIN; HEMOGLOBIN F; HYDROXYUREA; INFLUENZA VACCINE; IRON; LABETALOL; METHYLDOPA; NARCOTIC AGENT; PNEUMOCOCCUS VACCINE; TERATOGENIC AGENT; TRANSFERRIN;

AFRICA; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; BREAST FEEDING; CESAREAN SECTION; COUNSELING; DIET THERAPY; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DYSURIA; EARLY DIAGNOSIS; FERRITIN BLOOD LEVEL; FETUS OUTCOME; FEVER; FIRST TRIMESTER PREGNANCY; FLUID BALANCE; GENE MUTATION; GENETICS; GENOTYPE; GESTATIONAL AGE; HEALTH EDUCATION; HEMOGLOBIN SC DISEASE; HEMOGLOBINOPATHY; HIGH RISK PREGNANCY; HOME CARE; HOSPITAL PATIENT; HUMAN; HYDRATION; HYPERTENSION; INCIDENCE; INFECTION; INFLUENZA VACCINATION; IRON BLOOD LEVEL; IRON DEFICIENCY; LABOR INDUCTION; LABORATORY TEST; MATERNAL CARE; MATERNAL MORBIDITY; MATERNAL MORTALITY; OCCLUSION; OUTPATIENT; OXYGEN THERAPY; PLACENTA WEIGHT; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SECOND TRIMESTER PREGNANCY; SEPSIS; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; TRANSFERRIN BLOOD LEVEL; UNITED STATES; VASOOCCLUSIVE PAIN; VITAMIN SUPPLEMENTATION; ANALGESIA; DELIVERY; FEMALE; FETUS DISEASE; LABOR; PREGNANCY OUTCOME; PUERPERAL DISORDER; REVIEW;

ANALGESIA; ANEMIA, SICKLE CELL; DELIVERY, OBSTETRIC; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; LABOR, OBSTETRIC; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PUERPERAL DISORDERS;

EID: 79952022654     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2010.02.015     Document Type: Article

References (61)

1. World Health Organization. Sickle-cell anaemia: report by the secretariat. 59th World health Assembly; 2006.
2. Yu CK, Stasiowska E, Stephens A, et al. Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic. J Obstet Gynaecol 2009;29(6):512-6.
3. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330(23):1639-44.
4. National Institutes of Health Consensus Development Conference Proceedings. Hydroxyurea treatment for sickle cell disease, February 25-27, 2008.
5. Charche S, Scott J, Niebl J, et al. Management of SSD in pregnant patient. Obstet Gynecol 1980;55:407-10.
6. Powars DR, Sandhu M, Niland-Weiss J, et al. Pregnancy in SSD. Obstet Gynecol 1986;67:217-28.
7. Hoyert DL. Maternal mortality and related concepts. National Center for Health Statistics. Vital Health Stat 3 2007;33:1-13.
8. Samuels P. Hematologic complications of pregnancy. In: Gabbe SG, Niebyl JA, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 4th edition. Philadelphia: Churchill Livingstone; 2002. p. 1169-93.
9. Gilson GJ, Samaan S, Crawford MH, et al. Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: a longitudinal study. Obstet Gynecol 1997;89:957-67.
10. Halligan A, O'Brien E, O'Malley K, et al. Twenty four hour ambulatory blood pressure measurement in a primigravid population. J Hypertens 1993;11: 869-75.
11. Blackburn ST, Loper DL. Maternal adaptation to pregnancy. In: Polin RA, Fox WW, Abman SH, editors. Maternal, fetal, and neonatal physiology: a clinical perspective. Philadelphia (PA): WB Saunders; 1992. p. 201-12.
12. Awe RJ, Nicotra MB, Newsom TD, et al. Arterial oxygenation and alveolar-arterial gradients in term pregnancy. Obstet Gynecol 1979;53:182-6.
13. Kobak AJ, Stien PJ, Daro AF. Sickle cell anemia in pregnancy. A review of the literature and report of six cases. Am J Obstet Gynecol 1941;41:811-21.
14. Smith J, Espeland M, Bellevue R, et al. Pregnancy in sickle cell disease: experience of the cooperative study of sickle cell disease. Obstet Gynecol 1996;87(2): 199-204.
15. Koshy M, Burd L, Wallace D, et al. Prophylactic red-cell transfusions in pregnant patients with SSD. A randomized cooperative study. N Engl J Med 1988;319(22): 1447-52.
16. Serjeant GR, Loy LL, Crowther M, et al. Outcome of pregnancy in homozygous SSD. Obstet Gynecol 2004;103(6):1278-85.
17. Taylor JG. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 2008;3(5):e2095.
18. Adams JQ, Whitacre FE, Diggs LW. Pregnancy and sickle cell disease. Obstet Gynecol 1953;2:335-52.
19. Eisenstien MI, Posner AC, Friedman S. Sickle cell anemia in pregnancy: a review of the literature with additional case histories. Am J Obstet Gynecol 1956;72: 622-34.
20. Sun PM, Wilburn W, Raynor D, et al. SSD in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol 2001;184:1127-30.
21. Villers MS, Jamison MG, DeCastro LM, et al. Morbidity associated with SSD in pregnancy. Am J Obstet Gynecol 2008;1:e1-5.
22. Thame M, Lewis J, Trotman H, et al. The mechanisms of low birthweight in infants of mothers with homozygous SSD. Pediatrics 2007;120:686-92.
23. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008;148(2):94-101.
24. Wilkie D, Molokie R, Boyd-Seal D, et al. Patient reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J Natl Med Assoc 2010;102(1):18-27.
25. Goldberg CA. The ferrohemoglobin solubility test; its accuracy and precision together with values found in the presence of some abnormal hemoglobins. Clin Chem 1958;4:146-9.
26. Rahimy M, Gangbo A, Adjou R, et al. Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting. Blood 2000; 96(5):1685-9.
27. Bonds D. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Rev 2005;19:99-110.
28. Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957;180(4581):326-8.
29. Claster S, Vichinsky EP. Managing sickle cell disease. BMJ 2003;327(7424): 1151-5.
30. Markham MJ, Lottenberg R, Zumberg M. Role of phlebotomy in the management of hemoglobin SC disease: case report and review of the literature. Am J Hematol 2003;73(2):121-5.
31. Thinkhamrop J, Apiwantanakul S, Lumbiganon P, et al. Iron status in anemic pregnant women. J Obstet Gynaecol 2003;29:160-3.
32. Williams R, Wang W. Children with sickle cell disease may benefit from improved nutrition practices. J Am Diet Assoc Oct 1985;94:739-43.
33. Yan J, Hales B. Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in organogenesis stage mouse embryo. J Pharmacol Exp Ther 2006;319:613-21.
34. Thauvin-Robinet C, Maingueneau C, Robert E, et al. Exposure to hydroxyurea during pregnancy: a case series. Leukemia 2001;8:1309-11.
35. Diav-Citrin O, Hunnisett L, Sher G, et al. Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature. Am J Hematol 1999;60:148-50.
36. Hasley C, Roberts I. The role of hydroxyurea in sickle cell disease. Br J Haematol 2003;120:177-86.
37. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007;44(11): 1428-33.
38. Zaman K, Roy E, Arifeen S, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359:1555-64.
39. Hassel K. Pregnancy and sickle cell disease. Hematol Oncol Clin North Am 2005; 19:903-16.
40. Rees D. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003;120:744-52.
41. Gilstrap LC III, Cunningham FG, Whaley PJ. Acute pyelonephritis in pregnancy, an anterospective study. Obstet Gynecol 1981;57:409-13.
42. Castro O, Gladwin MT. Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management. Hematol Oncol Clin North Am 2005;19(5): 881-96.
43. Emerson GG, Lutty GA. Effects of sickle cell disease on the eye: clinical features and treatment. Hematol Oncol Clin North Am 2005;19(5):957-73.
44. Kototey-Ahulu FID. The sickle cell disease patient: natural history from a clinicoepidemiological study of the first 1550 patients of Korle Bu Hospital Sickle Cell Clinic. J Med Genet 1996;76:302-5.
45. Chang J, Golbus M, Kan Y. Antenatal diagnosis of sickle cell anaemia by direct analysis of the sickle mutation. Lancet 1981;318(8256):1127-9.
46. Kan Y, Trecartin R, Golbus M, et al. Prenatal diagnosis of B thalassaemia and sickle-cell anaemia experience with 24 cases. Lancet 1977;8006:269-71.
47. Steiner CMJ. Sickle cell disease patients in U.S. Hospitals, 2004. HCUP statistical brief #21. Rockville (MD): Agency for Healthcare Research and Quality; December 2006. p. 200.
48. Mohomed K. Prophylactic versus selective blood transfusion for sickle cell anaemia during pregnancy. Cochrane Database Syst Rev 1996;(2): CD000040.
49. Josephson C, Su L, Hillyer C, et al. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev 2007;21:118-33.
50. Faron G, Corbisier C, Tecco L, et al. First sickle cell crisis triggered by induction of labor in primigravida. Eur J Obstet Gynecol Reprod Biol 2001;94:304-6.
51. Platt O, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med 1991;325:11-6.
52. Ballas SK. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells. Am J Hematol 1991;36(2):122-30.
53. Adams S. Caring for the pregnant woman with sickle cell crisis. Prof Care Mother Child 1996;6:34-6.
54. Martin JJ, Moore GP. Pearls, pitfalls, and updates for pain management. Emerg Med Clin North Am 1997;15(2):399-415.
55. Firth PG, Alvin C. Sickle cell disease and anesthesia. J Am Anesthesiol 2004; 101(3):766-85.
56. Embury SH, Garcia JF, Mohandas N, et al. Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle cell anemia. N Engl J Med 1984;311:291-5.
57. Finer P, Blair J, Rowe O. Epidural analgesia in the management of labor pain and sickle cell crisis-a case report. Anesthesiology 1988;68(5):799-800.
58. Rappaport VJ, Velazquez M, Williams K. Hemoglobinopathies in pregnancy. Obstet Gynecol Clin North Am 2004;31(2):287-317.
59. Fort AT, Morrison JC, Berreras L, et al. Counseling the patient with SSD about reproduction. Pregnancy outcome does not justify the maternal risk. Am J Obstet Gynecol 1971;111:324.
60. Gaston MH, Verter JL, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 1986;314:1593-9.
61. Mansouri HA, Anfanan N. Sickle cell disease in pregnancy. Bahrain Medical Bulletin 2005;4:27-9.